Kimberly Murphy
Director/Board Member at ORAGENICS, INC.
Net worth: 26 500 $ as of 2024-04-29
Profile
Kimberly M.
Murphy is currently the Director at Oragenics, Inc. and an Independent Director at Blue Water Acquisition Corp.
II.
Previously, she served as the Chairman at Clarus Therapeutics, Inc. and Clarus Therapeutics Holdings, Inc. from 2020 to 2022.
She also worked as the Director-HPV & Gardasil Franchise at Merck & Co., Inc. from 1999 to 2005.
Additionally, she held positions as a Director at Biotechnology Innovation Organization, an Independent Non-Executive Director at Blue Water Biotech, Inc. from 2020 to 2023, and an Independent Director at Blue Water Acquisition Corp.
She was the Vice President at Novartis AG from 2014 to 2015 and at GSK Plc from 2011 to 2019, where she was responsible for the Influenza Franchise.
She also served as the Head-Meningococcal Franchise at Novartis Vaccines & Diagnostics, Inc. in 2010.
Ms. Murphy completed her undergraduate degree at Old Dominion University and holds an MBA from St. Joseph's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ORAGENICS, INC.
0.56% | 2024-03-14 | 25,000 ( 0.56% ) | 26 500 $ | 2024-04-29 |
Kimberly Murphy active positions
| Companies | Position | Start |
|---|---|---|
| ORAGENICS, INC. | Director/Board Member | 2020-04-30 |
Blue Water Acquisition Corp. II
 Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Director/Board Member | - |
Former positions of Kimberly Murphy
| Companies | Position | End |
|---|---|---|
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Director/Board Member | 2023-01-12 |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Chairman | 2022-10-30 |
| GSK PLC | Corporate Officer/Principal | 2018-12-31 |
| NOVARTIS AG | Corporate Officer/Principal | 2015-04-30 |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2010-02-28 |
Training of Kimberly Murphy
| Old Dominion University | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ORAGENICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| MERCK & CO., INC. | Health Technology |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Blue Water Acquisition Corp.
 Blue Water Acquisition Corp. Financial ConglomeratesFinance Blue Water Acquisition Corp. operates as a blank check company. It is incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez on May 22, 2020 and is headquartered in Greenwich, CT. | Finance |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Blue Water Acquisition Corp. II
Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Finance |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Kimberly Murphy
